Abstract

Emerging Applications of Metabolomics in Drug Development

Highlights

  • Metabolomics is a relatively new discipline in contrast to other well-established omics such as genomics, transcriptomics, and proteomics

  • The metabolic insights on diseases and drug efficacy could facilitate the discovery of novel therapeutic biomarkers of diseases that are of critical significance for drug discovery

  • Drug efficacy or metabolismassociated metabolic phenotypes open up an important window for performing precise clinical trial of either “old” or novel drug candidates

Read more

Summary

Introduction

Metabolomics is a relatively new discipline in contrast to other well-established omics such as genomics, transcriptomics, and proteomics. The metabolic insights on diseases and drug efficacy could facilitate the discovery of novel therapeutic biomarkers of diseases that are of critical significance for drug discovery. Tremendous efforts have been paid to discovery of novel drug targets by over whelmingly focus on genetic aspect, the successful cases were far less than expected because most diseases are consequences of complicated interactions between genetic and environmental factors (e.g gut microbiome and epigenome).

Results
Conclusion
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call